News

Published on 11 Apr 2024 on Zacks via Yahoo Finance

Fusion Pharmaceuticals Inc. (FUSN) Flat As Market Gains: What You Should Know


Article preview image

Fusion Pharmaceuticals Inc. (FUSN) closed the most recent trading day at $21.36, making no change from the previous trading session. The stock's change was less than the S&P 500's daily gain of 0.74%. Elsewhere, the Dow lost 0.01%, while the tech-heavy Nasdaq added 1.68%.

The the stock of company has risen by 124.84% in the past month, leading the Medical sector's loss of 4.72% and the S&P 500's gain of 0.8%.

NASDAQ.FUSN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Fusion (FUSN) to Report Q1 Earnings: Here's What to Expect

We expect Fusion Pharmaceuticals FUSN to beat expectations when it reports first-quarter 2024 res...

Zacks via Yahoo Finance 26 Apr 2024

Top 4 Health Care Stocks That May Plunge This Month - AstraZeneca (NASDAQ:AZN), Boston Scientific...

As of April 26, 2024, four stocks in the health care sector could be flashing a real warning to i...

Benzinga 26 Apr 2024

Fusion Pharmaceuticals Inc. (FUSN) Stock Moves -0.09%: What You Should Know

Fusion Pharmaceuticals Inc. (FUSN) closed the most recent trading day at $21.24, moving -0.09% fr...

Zacks via Yahoo Finance 17 Apr 2024

Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) is definitely on the radar of institutional investors who...

Key Insights Given the large stake in the stock by institutions, Fusion Pharmaceuticals' stock pr...

Simply Wall St. via Yahoo Finance 11 Apr 2024

Fusion Pharmaceuticals Inc. (FUSN) Flat As Market Gains: What You Should Know

Fusion Pharmaceuticals Inc. (FUSN) closed the most recent trading day at $21.36, making no change...

Zacks via Yahoo Finance 11 Apr 2024

31 European Countries That Offer Citizenship by Descent

In this article, we will take a look at 31 European Countries That Offer Citizenship by Descent. ...

Insider Monkey via Yahoo Finance 25 Mar 2024

Fusion (FUSN) Up 99% on $2.4B Buyout Offer From AstraZeneca

Fusion Pharmaceuticals FUSN signed a definitive agreement with AstraZeneca AZN. Per the agreement...

Zacks via Yahoo Finance 20 Mar 2024

AstraZeneca bets on next-generation cancer therapy with $2 billion Fusion deal

By Yadarisa Shabong and Manas Mishra (Reuters) -AstraZeneca said on Tuesday it will buy Canadian ...

Reuters via Yahoo Finance 19 Mar 2024

Why Fusion Pharmaceuticals Shares Are Trading Higher By Around 95%; Here Are 20 Stocks Moving...

Shares of Fusion Pharmaceuticals Inc. FUSN rose sharply in today’s pre-market trading after the...

Benzinga 19 Mar 2024

What Makes Fusion Pharmaceuticals Inc. (FUSN) a Strong Momentum Stock: Buy Now?

Momentum investing is all about the idea of following a stock's recent trend, which can be in eit...

Zacks via Yahoo Finance 15 Jan 2024